Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari 70126, Italy.
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 5265601, Israel.
Autoimmun Rev. 2016 Nov;15(11):1054-1061. doi: 10.1016/j.autrev.2016.07.030. Epub 2016 Aug 1.
HBsAg and HPV L1 proteins - the HBV and HPV antigens utilized in current vaccines - share amino acid sequences with human proteins such as cardiomyopathy-associated protein 5, titin, protein-arginine deiminase, E3 ubiquitin-protein ligase RNF19A, bassoon, G-protein coupled receptor for fatty acids, insulin isoform 2, and mitogen-activated protein kinase kinase kinase 10, inter alia. Many shared peptides are also part of immunopositive epitopes. The data 1) support the possibility of crossreactions between the two viral antigens and human proteins that, when altered, may associate with neuropsychiatric, cardiovascular and metabolic diseases such as multiple sclerosis, amyotrophic lateral sclerosis, diabetes, and sudden death; 2) confirm the concept that only vaccines based on sequences unique to pathogens might nullify potential crossreactivity risks in vaccination protocols.
HBsAg 和 HPV L1 蛋白 - 目前疫苗中使用的乙肝病毒和 HPV 抗原 - 与人蛋白如心肌病相关蛋白 5、titin、蛋白精氨酸脱亚氨酶、E3 泛素蛋白连接酶 RNF19A、bassoon、脂肪酸 G 蛋白偶联受体、胰岛素同工型 2 和丝裂原活化蛋白激酶激酶激酶 10 等具有氨基酸序列。许多共同的肽段也是免疫阳性表位的一部分。这些数据 1)支持两种病毒抗原与人蛋白之间可能发生交叉反应的可能性,当这些抗原发生改变时,可能与神经精神、心血管和代谢疾病如多发性硬化症、肌萎缩侧索硬化症、糖尿病和猝死相关;2)证实了只有基于病原体特有序列的疫苗才可能消除疫苗接种方案中潜在的交叉反应风险的概念。